03/20/2025
3:36 PM | Terns Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025
3:23 PM | Terns Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2025
3:10 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
5:10 PM | Gengos Andrew (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/25/2025
5:12 PM | Gengos Andrew (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:01 PM | Azelby Robert (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/24/2025
5:05 PM | Azelby Robert (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:25 PM | CITADEL ADVISORS LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
3:15 PM | Schonfeld Strategic Advisors LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
5:06 PM | Strauss David Eric (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
4:05 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TERN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Terns Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/05/2025
4:28 PM | BlackRock, Inc. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
6:25 PM | Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:27 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:28 PM | Jung Melita Sun (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:30 PM | FELLOWS DAVID A (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:31 PM | KINDLER JEFFREY B (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:35 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:36 PM | Terns Pharmaceuticals (Issuer)
Tripuraneni Radhika (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:37 PM | Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:30 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:30 PM | Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:30 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
5:26 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
5:04 PM | Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
6:10 AM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
5:22 PM | Terns Pharmaceuticals (Issuer)
Turner Heather D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/19/2024
5:30 PM | Terns Pharmaceuticals (Issuer)
Turner Heather D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:15 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
9:35 AM | Point72 Asset Management, L.P. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
6:00 PM | Terns Pharmaceuticals (Subject)
Vivo Capital Fund VIII, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:51 PM | Terns Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/12/2024
4:06 PM | Terns Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/05/2024
3:15 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G | |
09/17/2024
6:48 PM | Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:29 PM | ORBIMED ADVISORS LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/12/2024
5:10 PM | Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:01 AM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
5:00 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:09 PM | Terns Pharmaceuticals (Filer)
| Form 424B5 | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
 When you see what could happen – I think you’ll be excited. |
09/09/2024
3:30 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
3:40 PM | Terns Pharmaceuticals (Filer)
| Form 424B5 | |
09/09/2024
6:16 AM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:11 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
3:18 PM | CITADEL ADVISORS LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G | |
07/18/2024
4:33 PM | ORBIMED ADVISORS LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/17/2024
7:48 PM | OrbiMed Advisors III Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Asia GP III, L.P. (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:53 PM | GORDON CARL L (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
6:56 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
6:48 PM | ORBIMED ADVISORS LLC (Reporting)
Terns Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
6:51 PM | ORBIMED ADVISORS LLC (Reporting)
Terns Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
6:54 PM | ORBIMED ADVISORS LLC (Reporting)
Terns Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:28 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
5:36 PM | FELLOWS DAVID A (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:36 PM | GORDON CARL L (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:36 PM | KINDLER JEFFREY B (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:36 PM | Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:37 PM | Taylor Ann Elizabeth (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:38 PM | Terns Pharmaceuticals (Issuer)
Tripuraneni Radhika (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:03 PM | FELLOWS DAVID A (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:04 PM | KINDLER JEFFREY B (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:04 PM | GORDON CARL L (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:04 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:04 PM | Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:05 PM | Taylor Ann Elizabeth (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:05 PM | Terns Pharmaceuticals (Issuer)
Tripuraneni Radhika (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:15 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G/A | |
06/07/2024
7:30 AM | Soleus Capital Master Fund, L.P. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G | |
06/04/2024
5:05 PM | Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:06 PM | Terns Pharmaceuticals (Issuer)
Yoon Seokho Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:07 AM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:24 PM | Jung Melita Sun (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2024
4:29 PM | Jung Melita Sun (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:47 PM | Terns Pharmaceuticals (Issuer)
Vivo Capital Fund VIII, L.P. (Reporting)
Vivo Capital Surplus Fund VIII, L.P. (Reporting)
Vivo Capital VIII, LLC (Reporting)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
